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1998). Artery-restricted expression of ephrin-B2 has
also been demonstrated in adult mice and humans (Gale
et al., 2001; Shin et al., 2001). Analyses of mice lacking
ephrin-B2 (Adams et al., 1999; Wang et al., 1998) or
EphB4 (Gerety et al., 1999), as well as Xenopus laevis
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embryos injected with a dominant-negative form ofBethesda, Maryland 20892
EphB4 (Helbling et al., 2000), show that these factors
are required for normal blood vessel development. How-
ever, they do not appear to be required for the determi-Summary
nation of arterial or venous endothelial cell fate (Wang
et al., 1998), suggesting the action of other upstreamThe appearance of molecular differences between ar-
factors.terial and venous endothelial cells before circulation
We have previously shown that the Notch signalingsuggests that genetic factors determine these cell
pathway plays an important role in the expression oftypes. We find that vascular endothelial growth factor
artery-specific genes and repression of venous markers(vegf) acts downstream of sonic hedgehog (shh) and
within developing arteries (Lawson et al., 2001). Zebra-upstream of the Notch pathway to determine arterial
fish notch5 is expressed within the dorsal aorta (DA),cell fate. Loss of Vegf or Shh results in loss of arterial
concomitant with the appearance of ephrin-B2a, but isidentity, while exogenous expression of these factors
not found in veins. (We previously referred to zebrafishcauses ectopic expression of arterial markers. Micro-
notch5 as notch3 due to similarities to mouse and hu-injection of vegf mRNA into embryos lacking Shh activ-
man NOTCH3. Kortschak et al. (2001) have suggestedity can rescue arterial differentiation. Finally, activation
that the name notch5 is more appropriate). Zebrafishof the Notch pathway in the absence of Vegf signaling
embryos mutant for the neurogenic gene mindbombcan rescue arterial marker gene expression. These
(mib; Jiang et al., 1996; Schier et al., 1996) exhibit defectsstudies reveal a complex signaling cascade responsi-
in Notch signaling (Appel et al., 1999; Riley et al., 1999)ble for establishing arterial cell fate and suggest differ-
and display ectopic vein marker gene expression withinential effects of Vegf on developing endothelial cells.
the DA (Lawson et al., 2001). Conversely, endothelial-
specific expression of an activated form of notch5 canIntroduction
repress flt4 levels in veins (Lawson et al., 2001). Embryos
lacking Notch activity also fail to express ephrin-B2a andArteries and veins can be anatomically distinguished
notch5 within the DA. However, mib mutant embryos dowithin the adult vertebrate circulatory system (for exam-
exhibit expression of some arterial markers, suggestingple, see Gray, 1901). Larger-diameter arterial vessels
that other factors act in parallel to the Notch pathway
are exposed to the highest pressure and flow and are
to induce arterial differentiation.
characteristically surrounded by a thick medial layer
Among the potential molecules that may act upstream
consisting mostly of vascular smooth muscle cells (Gray, of the Notch pathway to induce arterial differentiation
1901; Stehbens, 1995). In contrast, venous vessels carry are members of the Hedgehog family of proteins (re-
efferent circulation of lower pressure, have less sur- viewed in Murone et al., 1999). Several studies suggest
rounding smooth muscle, and possess specialized an important role for sonic hedgehog (Shh), in particular,
structures, such as valves, to ensure blood flow in a during blood vessel development. Zebrafish embryos
single direction. Although differences in fluid dynamics that are mutant for sonic you (syu), which encodes the
within the circulatory system play a role in determining zebrafish homolog of Shh (Schauerte et al., 1998), fail
the characteristic structure of an artery or vein (Steh- to exhibit normal trunk circulation (Chen et al., 1996).
bens, 1995), recent evidence suggests that the identity Consistent with these observations, syu mutant em-
of endothelial cells lining these vessels is established bryos display defects in the formation of the DA and
before the onset of circulation by genetic mechanisms posterior cardinal vein (PCV), although the initial devel-
during embryonic development (Adams et al., 1999; Ger- opment of vascular cells appears normal, as indicated
ety et al., 1999; Lawson et al., 2001; Wang et al., 1998). by the expression of the endothelial cell marker fli1
Molecular differences between arterial and venous (Brown et al., 2000). Furthermore, recent work has
endothelial cells have been demonstrated during embry- shown that Shh can promote angiogenic blood vessel
onic development in chick, mouse, and zebrafish. In growth in part by inducing the expression of vascular
all of these vertebrate organisms, the transmembrane endothelial growth factor (vegf) as well as Angio-
ligand ephrin-B2 is expressed in endothelial cells lining poietin-1 and -2 (Pola et al., 2001). These observations
only arteries, while, in most cases, its receptor, EphB4, suggest that Shh may cooperate with vascular-specific
is expressed predominantly in venous endothelial cells growth factors during the development of the embryonic
(Lawson et al., 2001; Moyon et al., 2001; Wang et al., vasculature.
In this study we show that endothelial cells in zebrafish
embryos lacking Shh activity fail to undergo arterial dif-1Correspondence: bw96w@nih.gov
ferentiation, as defined by the expression of artery-spe-2 Present address: Artemis Pharmaceuticals, Spemannstr.35, 72076
Tu¨bingen, Germany. cific markers, such as ephrin-B2a, while injection of
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mRNA encoding Shh can induce ectopic vascular ex-
pression of ephrin-B2a. We further show that embryos
lacking Shh activity fail to express vegf within their so-
mites, and exogenous addition of Vegf in these embryos
can rescue vascular ephrin-B2a expression, indicating
that Vegf is sufficient downstream of Shh to induce arte-
rial differentiation. Consistent with these observations,
reduction of Vegf activity using antisense morpholino
oligonucleotides phenocopies the arterial differentiation
defect found in embryos lacking Shh activity. Finally,
we show that Vegf is unable to rescue artery marker gene
expression in embryos lacking Notch function, while
exogenous Notch activity can induce arterial differentia-
tion in the absence of Vegf signaling. Together with our
previous work (Lawson et al., 2001), these observations
describe a signaling cascade that is responsible for in-
ducing arterial differentiation and suggests that endo-
thelial cell progenitors respond differentially to Vegf dur-
ing this process.
Results
sonic hedgehog Is Required for Arterial
Differentiation
To investigate the potential role of the Shh pathway
during arterial endothelial cell differentiation, we first
determined the vascular pattern of ephrin-B2a mRNA
expression associated with loss of shh function in the
zebrafish you-type class of mutants (van Eeden et al.,
1996). We utilized embryos carrying null mutations for
sonic-you (syu) or you-too (yot), which encode the zebra-
fish orthologs of Shh and Gli2, a downstream effector
of Hh signaling, respectively (Karlstrom et al., 1999;
Figure 1. sonic hedgehog Is Required for Arterial Differentiation
Schauerte et al., 1998). In wild-type sibling embryos
(A) Line drawing of a zebrafish embryo at approximately 24 hr post
derived from an incross of heterozygous syut4 adults, fertilization (hpf); modified from Kimmel et al. (1995). Lateral view;
normal expression of ephrin-B2a is seen in the DA at 26 anterior is to the left; dorsal is up; scale bar is 250 m. Boxed region
hr post fertilization (hpf; Figure 1B). In contrast, embryos indicates views for (B)–(F).
(B–E) Whole-mount in situ hybridization of ephrin-B2a mRNA ex-mutant for syut4 (Figure 1C) or yotty119 (Figure 1D) fail to
pression within the trunks of zebrafish embryos at 26 hpf; lateralexpress ephrin-B2a within their vasculature. Vascular
views; anterior is to the left; dorsal is up; scale bar is 100 m.ephrin-B2a is also absent when wild-type embryos are
(B) Expression of ephrin-B2a in the DA (indicated by red arrow) of
exposed to 25 M cyclopamine (Figure 1E), a potent a wild-type sibling; nc, notochord; nt, neural tube.
inhibitor of Shh signaling (Cooper et al., 1998; Incardona (C and D) Lack of ephrin-B2a expression in embryos mutant for (C)
et al., 1998; Neumann et al., 1999). Previous studies syut4 or (D) yot ty119.
(E) Embryo at 24 hpf following treatment with 25 M cyclopamine;have shown that endothelial cells are present in you-type
note the lack of ephrin-B2a expression.mutants, as indicated by the expression of fli1 (Brown et
(F) flt4 expression in a yot ty119 embryo.al., 2000). Furthermore, we find that these cells form a
(G and H) Cross-sections of the trunks of zebrafish embryos injected
single lumenized vessel that remains positive for the with (G) 12.5 pg -galactosidase (-gal) or (H) 12.5 pg -gal and 25
venous marker flt4 in yotty119 or syut4 mutant embryos pg shh mRNA; dorsal is up; scale bar is 50 m.
(Figure 1F and data not shown). (G) Normal ephrin-B2a expression in the DA (indicated by red arrow),
but not in PCV (blue arrowhead).To determine whether Shh is sufficient to induce arte-
(H) Expanded ephrin-B2a expression (red bracket) into the regionrial differentiation, we injected one- to two-cell stage
of the PCV and lumenized ectopic arterial vessel (arrowhead) arewild-type zebrafish embryos with mRNA encoding Shh
apparent in shh mRNA-injected embryos.
and assayed for expression of ephrin-B2a transcript.
Embryos that were uninjected or injected with mRNA
encoding -galactosidase (-gal) exhibit expression of vegf Rescues Arterial Differentiation
in the Absence of shh Signalingephrin-B2a within the DA, but not in the PCV (Figure 1G;
79 out of 79 embryos in two experiments). Embryos Recent work in mouse has shown that Shh can modulate
angiogenesis by inducing the expression of vegf mRNAinjected with -gal and 25 pg of shh mRNA exhibit ex-
panded expression of ephrin-B2a into the region of the (Pola et al., 2001). To determine whether this was the
case during zebrafish development, we assayed vegfPCV and ectopic formation of lumenized ephrin-B2a-
positive vessels (Figure 1H; 40 out of 76 embryos in two transcript levels in embryos lacking Shh activity. At the
15-somite stage (ss), wild-type sibling embryos expressrepresentative experiments).
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The concomitant loss of ephrin-B2a and vegf expres-
sion in embryos lacking Shh activity suggests the possi-
bility that vegf may provide a signal for arterial differenti-
ation downstream of Shh. Therefore, we determined
whether exogenous Vegf was sufficient to rescue
ephrin-B2a expression in the absence of Shh. In most
vertebrate embryos, including zebrafish (Liang et al.,
2001), two major Vegf isoforms are present: a 121-amino
acid isoform (Vegf121) that is freely diffusible and a 165-
amino acid protein (Vegf165) that is associated with the
extracellular matrix (reviewed in Robinson and Stringer,
2001). We injected mRNA encoding enhanced green
fluorescent protein (EGFP), Vegf121, or Vegf165 into em-
bryos lacking Shh activity and assayed expression of
ephrin-B2a at 25 hpf. Embryos injected with 50 pg of
EGFP mRNA and treated with ethanol vehicle exhibit
normal DA expression of ephrin-B2a (data not shown),
while those treated with 25 M cyclopamine failed to
express ephrin-B2a (Figure 3A; 156 out of 159 embryos
in three experiments). Injection of 50 pg of mRNA encod-Figure 2. shh Controls Somite Expression of vegf
ing Vegf121 into embryos subsequently exposed to 25(A–C, E, and F) Flat mounts of embryos following whole-mount in
M cyclopamine rescues expression of ephrin-B2asitu hybridization for vegf mRNA at the 15 ss; dorsal views of the
within the trunk (Figure 3B; 74 out of 127 embryos intrunk; anterior is to the left.
(D) Lateral view of an embryo following whole-mount in situ hybrid- three experiments). In addition, we injected embryos
ization for vegf mRNA at 24 hpf; anterior is to the left; dorsal is up; derived from an incross of yotty119 heterozygous adults
scale bars are (A–C) 250 m and (D–F) 50 m. with mRNA encoding either Vegf121 (50 pg) or Vegf165
(A) Wild-type embryo; arrow indicates expression within the hypo-
(200 pg). Wild-type siblings injected with either isoformchord, which is located between the somites; arrowhead indicates
display expanded regions of ephrin-B2a expressionsomite expression.
(Figures 3C and 3E). Uninjected yotty119 mutant sibling(B) syut4 mutant embryo lacking somite and hypochord vegf ex-
pression. embryos fail to express ephrin-B2a within the trunk vas-
(C) yot ty119 mutant embryo; note hypochord expression (arrow), but culature (for example, see Figure 1D; 21 out of 21 mutant
lack of somite expression. embryos in two experiments). We find that yotty119 mutant
(D) Twenty-four hour post fertilization embryo following exposure
embryos injected with mRNA encoding either Vegf121to 25 M cyclopamine; arrow indicates hypochord expression; nc,
(Figure 3D; 32 out of 35 mutant embryos in two experi-notochord.
ments) or Vegf165 (Figure 3F; 41 out of 41 mutant embryos(E) Embryo injected with 12.5 pg -gal tracer mRNA.
(F) Embryo injected with 12.5 pg -gal and 25 pg shh mRNA; asterisk in two experiments) display ephrin-B2a expression
indicates injected side. within the trunk vessels.
Recent data indicate that angioblasts are restricted
to an arterial or venous cell fate at midsomitogenesis
(the 7–12 ss) in zebrafish embryos (Zhong et al., 2001).vegf within the medial aspect of the somites, as pre-
We find that, consistent with a role for Vegf during thisviously documented (Liang et al., 1998), and in the hypo-
process, vegf mRNA is expressed within the somites atchord (Figure 2A), a structure located between the so-
the 10 ss (Figure 3G). In addition, double in situ hybrid-mites and ventral to the notochord in amphibian and
ization with riboprobes against vegf and its receptor,fish embryos (Cleaver et al., 2000; Eriksson and Lofberg,
flk1, show that migrating angioblasts are in close prox-2000). Embryos mutant for syut4 fail to express vegf
imity to the source of Vegf at this time (Figure 3H).mRNA in the hypochord or somites (Figure 2B). In yotty119
mutant embryos (Figure 2C) and wild-type embryos
treated with 25 M cyclopamine (Figure 2D), vegf ex- vegf Is Required for Arterial Differentiation
pression is lost within the somites but persists within Our results indicate that Vegf is sufficient downstream
the hypochord. of Shh to induce arterial differentiation and suggest that
To determine whether Shh could also induce expres- the loss of ephrin-B2a expression in you-type mutants
sion of vegf transcript, we injected mRNA encoding Shh is due to the loss of Vegf signaling. To determine whether
into two- or four-cell stage embryos and assayed for Vegf is required for arterial differentiation, we utilized
the expression of vegf at the 15 ss. Wild-type embryos antisense morpholino oligonucleotides (Nasevicius and
injected with only -gal mRNA show normal expression Ekker, 2000) to reduce Vegf activity in zebrafish em-
of vegf within the somites (Figure 2E; 78 out of 78 em- bryos. Embryos injected with 10 ng of control morpho-
bryos in two experiments) and hypochord (data not lino display normal expression of ephrin-B2a mRNA in
shown; the hypochord is not visible in the focal plane the DA at 26 hpf (Figure 4A; see Supplemental Table S1
imaged), while embryos injected with 25 pg of shh mRNA at http://www.developmentalcell.com/cgi/content/full/
exhibit upregulation of vegf within the somites (Figure 3/1/127/DC1), while embryos injected with the same
2F; 75 out of 94 embryos in two representative experi- amount of Vegf morpholino exhibit a severe reduction
or loss of arterial ephrin-B2a expression (Figure 4B; seements).
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Figure 4. Loss of Vegf Function Perturbs Arterial-Venous Differenti-
ation
(A–F) Whole-mount in situ hybridization of zebrafish embryos at 26
hpf; lateral views; dorsal is up; anterior is to the left; scale bar is
Figure 3. Vegf Rescues Arterial Differentiation in the Absence of
50 m.
Shh Signaling
(A) Normal ephrin-B2a expression in DA (red arrowhead) of embryo
(A–F) Whole-mount in situ hybridization for ephrin-B2a expression injected with control morpholino; nc, notochord, nt, neural tube.
at 24 hpf; lateral views; anterior is to the left; dorsal is up; scale bar (B) Loss of DA ephrin-B2a expression in an embryo injected with
is 50 m. 10 ng of Vegf morpholino.
(A) Embryo injected with 50 pg EGFP mRNA and exposed to 25 M (C) PCV-restricted flt4 expression (blue arrowhead) in control mor-
cyclopamine; nc, notochord, nt, neural tube. pholino-injected embryos (black arrow indicates normal expression
(B) Embryo injected with 50 pg of vegf 121 mRNA and treated with within a segmental vessel); note the lack of expression in the region
25 M cyclopamine; red arrowhead indicates presence of ephrin- of the DA (indicated by red bracket).
B2a-positive cells in the position of the DA. (D) Ectopic flt4 expression in the DA in Vegf morpholino-injected
(C) Ectopic ephrin-B2a expression (indicated by arrows) in a wild- embryos. Red arrows indicate expression of flt4 in cells of the dorsal
type embryo injected with 50 pg vegf 121 mRNA. roof of the DA.
(D) Arrowhead indicates ephrin-B2a expression in a yot ty119 mutant (E) notch5 expression in DA (red arrowhead) of an embryo injected
embryo injected with 50 pg of vegf 121 mRNA. with control morpholino; white asterisk indicates neural tube and
(E) Wild-type sibling injected with 200 pg of mRNA encoding Vegf 165 black arrowhead shows pronephric expression outside the focal
displays ectopic ephrin-B2a expression in the region of the PCV plane.
(arrows). (F) Embryo injected with 10 ng of Vegf morpholino; note the decrease
(F) A yot ty119 mutant embryo injected with vegf 165 mRNA displays in DA notch5 expression, but no effect on neural tube or pronephric
ephrin-B2a expression in the region of the DA (indicated by red duct expression.
arrowhead). (G and H) Differential interference contrast (DIC) images of live albb4
(G and H) Dorsal views of ten-somite stage embryos; anterior is up; zebrafish embryos at 36 hpf. Lateral views; dorsal is up; anterior is
scale bar is 250 M. to the right; scale bar is 25 m
(G) Expression of vegf mRNA within the somites. (G) Embryo injected with 10 ng control morpholino; lumens of the
(H) Double staining for vegf mRNA (white arrowheads) and flk1, which DA (red bracket) and PCV (blue bracket) are indicated.
is expressed in migrating angioblasts (black arrows) at this time. (H) Embryo injected with 10 ng Vegf morpholino. Lumen of the DA
is indicated by red bracket; an abnormal narrowing of the DA can
be seen (indicated by black arrows). Note the presence of cells withSupplemental Table S1). To determine the effects on
endothelial morphology (black arrowheads) in close proximity to the
venous cell fate, we assayed for expression of flt4, which notochord.
is initially expressed in both arterial and venous primor-
dia but becomes restricted to venous vessels by 24 hpf
(Thompson et al., 1998). Embryos injected with control
morpholino show normal downregulation of flt4 in the
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DA by 26 hpf (Figure 4C; see Supplemental Table S1),
whereas injection of Vegf morpholino results in persis-
tent expression of flt4 in the DA (Figure 4D; see Supple-
mental Table S1). Since the patterns of ephrin-B2a and
flt4 expression in embryos injected with Vegf morpholino
were similar to those in embryos lacking Notch activity
(Lawson et al., 2001), we assayed for arterial expression
of notch5 mRNA. Expression of notch5 is detected in
the DA, pronephric duct, and neural tube of wild-type
embryos injected with the control morpholino (Figure
4E; see Supplemental Table S1). In contrast, injection
of 10 ng of Vegf morpholino results in a specific loss of
notch5 expression from the DA, while neural tube and
pronephric expression is not affected (Figure 4F; see
Supplemental Table S1). We observe similar results us-
ing a second morpholino directed to the vegf 5 untrans-
lated region (Vegf A-3; Nasevicius et al., 2000; see Sup-
plemental Table S1; data not shown).
We find defects in vascular morphology and circula-
tory patterns in Vegf morpholino-injected embryos, con-
sistent with perturbation of arterial and venous identity.
Embryos injected with 10 ng of control morpholino ex-
hibit normal vascular morphology, as indicated by fully
lumenized, well-defined trunk vessels (Figure 4G) and
normal circulatory patterns (see Supplemental Table
S1). In contrast, zebrafish embryos injected with 10 ng
of Vegf morpholino display a disorganized trunk vessel
plexus and poorly defined boundaries between the DA
and PCV, although endothelial cells can be seen immedi-
ately ventral to the notochord, indicating that their mi-
gration and localization is not affected (Figure 4H).
Consistent with these morphological defects, Vegf mor-
pholino-injected embryos often fail to exhibit trunk or
head circulation (see Supplemental Table S1), as has
been previously documented (Nasevicius et al., 2000).
In addition, we find that a proportion of embryos injected Figure 5. Interaction of the Notch Signaling Pathway and vegf
with the Vegf morpholino (see Supplemental Table S1) (A–J) Lateral views; anterior is to the left; dorsal is up; embryos at
display arterial-venous shunts between the DA and PCV, 25 hpf.
(A and B) Whole-mount in situ hybridization for vegf mRNA; scalesimilar to those we have previously described in em-
bar is 100 m.bryos lacking Notch function (Lawson et al., 2001). Em-
(A) Wild-type sibling.bryos injected with 10 ng of Vegf morpholino do not
(B) Embryo mutant for mibta52b.
exhibit overt morphological defects at 24–26 hpf and (C) flk1 expression in an uninjected wild-type sibling embryo. Note
display normal development of the notochord and so- the higher expression of flk1 within the DA (red arrowhead) than the
mites (data not shown and Nasevicius et al., 2000). PCV (blue arrow); nc, notochord, nt, neural tube.
(D) Uninjected mibta52b mutant embryo with flk1 expression similar
to its wild-type sibling in (C).Notch Signaling Mediates Arterial Differentiation
(E) Wild-type sibling injected with 20 pg mRNA encoding Vegf121;Downstream of vegf note the increased flk1 expression in PCV (black arrows).
The loss of arterial marker gene expression and ectopic (F) mibta52b mutant embryo injected with 20 pg of mRNA encoding
flt4 transcripts in the DA in Vegf morpholino-injected Vegf121 also expresses flk1 throughout the vasculature.
(G) notch5 expression in a wild-type sibling embryo injected withembryos is similar to that seen in embryos with defective
EGFP mRNA. DA expression is indicated by red arrowhead.Notch signaling (Lawson et al., 2001), suggesting that
(H) Lack of notch5 expression in embryo mutant for mibta52b andvegf and the Notch pathway act in a common signaling
injected with EGFP mRNA.
cascade to induce arterial differentiation. It is also possi- (I) Wild-type sibling injected with 20 pg of vegf121 mRNA; note the
ble that vegf expression may be absent in embryos lack- ectopic notch5 expression within PCV (black arrows).
ing Notch activity, as is the case in embryos lacking Shh (J) Mutant mibta52b embryo injected with 20 pg of vegf121 mRNA show-
ing lack of notch5 expression. Inset shows rare induction (see Sup-(see above). To determine whether vegf is affected by
plemental Table S2 at http://www.developmentalcell.com/cgi/Notch signaling, we assayed for its expression in mibta52b
content/full/3/1/127/DC1) of notch5 expression in DA.mutant embryos. Although the product of the mib gene
(C–J) Scale bar is 50 m.
is unknown, many of the phenotypes in mibta52b mutant
embryos are similar to those in embryos mutant for the
Notch ligand deltaA (Appel et al., 1999). Furthermore, we dominant-negative inhibitor of Notch signaling (Lawson
et al., 2001). Wild-type siblings exhibit normal expres-have previously demonstrated that the vascular defects
associated with mibta52b can be phenocopied using a sion of vegf mRNA within the somites (Figure 5A) and
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hypochord (data not shown) at 24 hpf. Consistent with sequence [TG(uas:myc-notch1a-intra); Scheer and
somite boundary defects in mibta52b mutant embryos (Ji- Campos-Ortega, 1999], and embryos were injected with
ang et al., 1996), the pattern of vegf expression appears 10 ng of either control or Vegf morpholino. The embryos
to be affected (Figure 5B), although vegf mRNA levels were allowed to develop and were heat-shocked and
are relatively normal compared to those in embryos lack- processed as described in Experimental Procedures.
ing Shh function (compare Figure 5B and Figures Embryos injected with 10 ng of control morpholino that
2B–2D). did not express ectopic Notch1a-intra (determined by
In addition to vegf, we investigated the expression of absence of immunostaining for the myc epitope) show
the zebrafish Vegf receptor-2 homolog flk1 in mibta52b the normal pattern of notch5 (Figure 6A) and ephrin-
mutant embryos. As shown previously (Liao et al., 1997), B2a (Figure 6F) transcript within the DA, while embryos
flk1 is expressed at higher levels within the DA than injected with Vegf morpholino exhibit reduction of arte-
within the PCV in wild-type sibling embryos at 24 hpf rial notch5 (Figure 6B) and ephrin-B2a (Figure 6G) tran-
(Figure 5C) and remains normal in embryos mutant for script. In contrast, embryos expressing exogenous
mibta52b (Figure 5D; see Supplemental Table S2 at http:// Notch1a-intra (as indicated by the brown staining in
www.developmentalcell.com/cgi/content/full/3/1/127/ Figures 6C–6E, 6H, and 6I) that had been injected with
DC1). Recent evidence in zebrafish has shown that flk1 10 ng control morpholino showed ectopic arterial marker
is upregulated throughout the vasculature by Vegf, re- gene expression. This observation is in contrast to our
sulting in ectopic expression within the PCV (Liang et previous work (Lawson et al., 2001) and is likely due to
al., 2001). We determined whether this response to vegf a difference in timing following heat shock, as we have
required intact Notch signaling. In wild-type sibling em- allowed a longer lag period to elapse in the experiments
bryos, injection of 20 pg of vegf121 mRNA caused expres- presented in this study (see Experimental Procedures).
sion of flk1 throughout the vasculature, including the notch5 appeared less responsive than ephrin-B2a to
region of the PCV at 25 hpf (Figure 5E; see Supplemental exogenous Notch1a-intra, with about 25% of embryos
Table S2). A similar effect was observed in mibta52b mu- displaying detectable ectopic notch5 expression con-
tant embryos, as ectopic expression of flk1 was noted fined to a few scattered cells within the PCV (Figures
following injection of 20 pg of mRNA encoding Vegf121 6C and 6D; see Supplemental Table S3 at http://www.
(Figure 5F; see Supplemental Table S2). Therefore, ec- developmentalcell.com/cgi/content/full/3/1/127/DC1).
topic induction of flk1 expression by Vegf does not re- In contrast, many more ephrin-B2a-positive cells were
quire Notch activity. found within the PCV of all sibling embryos with
Despite being responsive to Vegf121, mibta52b mutant Notch1a-intra expression (Figure 6H; see Supplemental
embryos fail to express arterial markers, such as notch5 Table S3). We also find that most embryos expressing
and ephrin-B2a (Lawson et al., 2001). To determine Notch1a-intra that were injected with 10 ng of Vegf mor-
whether vegf could bypass the requirement for Notch pholino exhibit both notch5 (Figure 6E; see Supplemen-
signaling, we injected mRNA encoding Vegf121 into em- tal Table S3) and ephrin-B2a (Figure 6I; see Supplemen-
bryos derived from an incross of heterozygous mibta52b tal Table S3) within the DA, with ectopic PCV expression
parents and assayed for artery marker gene expression also apparent, indicating that activation of the Notch
at 25 hpf. Expression of notch5 is normal in wild-type pathway in the absence of vegf signaling can rescue
siblings injected with EGFP mRNA or left uninjected artery differentiation.
(Figure 5G; see Supplemental Table S2), while ectopic
expression within the region of the PCV is noted in wild-
Discussiontype embryos injected with 20 pg of vegf121 mRNA (Figure
5I; see Supplemental Table S2). Embryos mutant for
mibta52b injected with EGFP or left uninjected fail to ex- Although anatomical differences between arteries and
press notch5 in the DA or neural tube (Figure 5H; see veins have long been known, it was not until recently
Supplemental Table S2). The majority of mibta52b mutant that molecular markers could distinguish the endothelial
embryos fail to express notch5 mRNA within the DA cells lining these vessels within the circulatory system
when injected with 20 pg of mRNA encoding Vegf121 (Wang et al., 1998). This finding, together with the ap-
(Figure 5J; see Supplemental Table S2). notch5 expres- pearance of these markers before circulation, has led
sion is apparent in a very small percentage of mutant to the hypothesis that arterial-venous differentiation is
embryos (Figure 5J, inset; see Supplemental Table S2). governed by genetic mechanisms (Wang et al., 1998).
We have noted similar results in response to 50 pg of In this study, we describe a cascade of well-known sig-
vegf121 mRNA and when using ephrin-B2a as a probe naling factors (Figure 7) that is responsible for proper
(data not shown). arterial-venous differentiation during embryonic vascu-
The failure of Vegf to induce arterial marker gene ex- lar development.
pression in mibta52b mutant embryos suggests that Notch
signaling is required downstream of vegf to induce arte-
Shh Regulates Arterial Differentiationrial differentiation. To determine whether activation of
by Inducing vegf Expressionthe Notch pathway is sufficient to rescue arterial differ-
We find that embryos lacking Shh activity fail to expressentiation in the absence of Vegf, we utilized a two-com-
ephrin-B2a within their blood vessels, similar to embryosponent transgenic system. Adult fish expressing the
lacking Vegf (this study) or Notch function (Lawson etyeast transactivator GAL4 driven by the zebrafish heat
al., 2001), while exogenous Shh induces ectopic forma-shock protein 70 promoter [TG(hsp70:gal4); Lawson et
tion of arteries within the trunk of zebrafish embryos.al., 2001; Scheer et al., 2001] were crossed with fish
Other arterial markers, such as deltaC (Smithers et al.,harboring a myc-tagged form of the zebrafish Notch1a
intracellular domain driven by the upstream activating 2000) and notch5, respond in a similar fashion to
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Figure 7. Model of Signaling Pathways Responsible for Arterial-
Venous Differentiation
Diagram of a cross-section through a zebrafish trunk at approxi-
mately 24 hpf. NT, neural tube; NC, notcochord; DA, dorsal aorta;
PCV, posterior cardinal vein.
vegf. Embryos lacking Shh activity do not express vegf
mRNA within their somites, and injection of mRNA en-Figure 6. Notch Signaling Induces Arterial Differentiation Down-
coding Shh induces the expression of somitic vegf,stream of vegf
which, in turn, acts on endothelial cells to drive arterial(A–I) All embryos were subject to heat shock as described in Experi-
mental Procedures. differentiation (Figure 7).
(A) Embryo without Notch1a-intra expression (as evidenced by the Although Shh acts upstream of Vegf to regulate arte-
lack of myc-positive nuclei) injected with 10 ng control morpholino; rial differentiation, we cannot rule out a direct role for
notch5 expression in the DA is indicated by red arrowhead; nc, Shh on endothelial cells during vascular development.
notochord, nt, neural tube.
The Shh receptor patched1 is expressed in multiple cell(B) Embryo without Notch1a-intra expression injected with 10 ng
types associated with blood vessels in mouse, includingVegf morpholino; note the lack of notch5 DA expression.
(C and D) Images from the same embryo injected with 10 ng control endothelial cells (Pola et al., 2001). Furthermore, angio-
morpholino and expressing Notch1a-intra (brown staining). Note genic blood vessel growth exhibits qualitative differ-
ectopic notch5-positive cells in the PCV (indicated by black arrows); ences in response to Vegf or Shh alone, possibly due
white arrowhead indicates expression in pronephric duct outside to the ability of Shh to induce the expression of multiple
the plane of focus.
endothelial growth factors, including angiopoietin-1(E) Embryo injected with 10 ng Vegf morpholino and expressing
and -2 as well as vegf itself (Pola et al., 2001). ThisNotch1a-intra; the red arrowhead indicates expression of notch5
within the DA, and the black arrow shows region of ectopic PCV may explain the ability of exogenous Shh to induce the
expression. formation of ectopic lumenized vessels in zebrafish em-
(F) Embryo not expressing Notch1a-intra and injected with 10 ng bryos, while Vegf is unable to elicit this effect. Further-
control morpholino with normal DA ephrin-B2a expression (red ar- more, embryos lacking Shh activity often fail to form
rowhead).
two distinct trunk axial vessels, a phenotype that is more(G) Embryo not expressing Notch1a-intra injected with 10 ng Vegf
severe than that observed in embryos lacking Vegf (thismorpholino and lacking DA ephrin-B2a expression.
study) or Notch function (Lawson et al., 2001). These(H) Embryo expressing Notch1a-intra (brown staining) and injected
with 10 ng control morpholino exhibits ectopic ephrin-B2a expres- observations suggest that Shh may affect the morpho-
sion within the PCV (indicated by black arrows); normal DA position genesis of blood vessels through pathways other than
is indicated by red arrowhead. those involving vegf. In addition, it remains a possibility
(I) Notch1a-intra-positive embryo injected with 10 ng vegf morpho-
that Shh plays a direct role in blood vessel development,lino. Note expression of ephrin-B2a within the DA (red arrowhead);
although it does not appear to be a proximal factor inectopic PCV expression is also apparent (black arrow).
determining arterial cell fate.(A–I) Scale bar is 50 m.
Notch Signaling Acts Dowstream of Vegf
changes in Shh function (A.M.V., unpublished data), sug- to Induce Arterial Differentiation
gesting that Shh is a major upstream regulator of arterial Our experiments demonstrate that the Notch signaling
differentiation. Our observations indicate that the role pathway acts downstream of Vegf during arterial differ-
entiation. We have previously shown that Notch activityof Shh during this process is to induce expression of
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is necessary for the expression of some arterial markers appear to respond more robustly to these factors. Alter-
natively, angioblasts most proximal to, or those first to(Lawson et al., 2001). We now demonstrate that Notch
is also sufficient to induce ectopic artery marker gene migrate into, the midline may preferentially receive a
Vegf signal and become specified as arterial progeni-expression in veins and is able to rescue ephrin-B2a
and notch5 expression in the absence of Vegf. In light tors. In either case, as lineage-restricted arterial progen-
itors migrate to the midline and come in proximity toof these findings and the observation that flk1 displays
artery-restricted expression even in the absence of the source of Vegf, they respond by inducing expression
of notch5, which, in turn, leads to differentiation.Notch signaling, we find it of interest to note that expres-
sion of some arterial marker genes is also unaffected in Recent studies in zebrafish indicate that the hairy-
related transcription factor, gridlock (grl), is required formibta52b mutant embryos (Lawson et al., 2001). In addi-
tion, ephrin-B2a displays ectopic expression within the arterial differentiation. Zebrafish embryos mutant for grl
exhibit defects in DA formation (Zhong et al., 2000), andPCV more readily than notch5 in response to Notch1a-
intra, while rescue of notch5 expression is often con- reduction of Grl by morpholino oligonucleotides results
in a loss of ephrin-B2a from the DA (Zhong et al., 2001).fined to the DA, with little ectopic expression apparent.
Similarly, rescue of ephrin-B2a by Vegf in embryos lack- Furthermore, there is evidence supporting a role for grl
downstream of the Notch pathway during this process,ing Shh often appears only within the region of the DA
(for example, see Figures 3B and 3F). Taken together, as the expression of both grl and its mouse homolog,
HRT2, can be induced by Notch activity (Nakagawa etthese results suggest differential sensitivity of arterial
genes to Notch and Vegf signaling and indicate the ac- al., 2000; Zhong et al., 2001). These findings, as well as
the similiarity of vascular defects observed in embryostion of additional unknown factors that contribute to
arterial differentiation and may confer spatial informa- lacking grl to those lacking Shh, Vegf ,or Notch activity,
suggest that grl functions within the pathway describedtion upon the developing DA.
Vegf is known to elicit a wide range of responses in here (Figure 7) during arterial differentiation. In addition,
activation of notch5 or exogenous expression of grl canendothelial cells, including proliferation, migration, and
survival (Ferrara, 1999). Our studies indicate that migra- inhibit expression of the venous marker, flt4 (Lawson et
al., 2001; Zhong et al., 2001). Arterial expression of flt4tion is not affected by the lack of Vegf, as endothelial
cells move to the midline and are observed in the posi- is normally downregulated by 24 hpf (Thompson et al.,
1998), a time at which notch5 and grl are expressed intion of the DA in embryos injected with Vegf morpho-
linos. At this time, we cannot rule out the possibility that the DA (Lawson et al., 2001; Zhong et al., 2001). An
obvious discrepancy in these observations is that grl isVegf provides a proliferative or survival signal that is
responsible for expanding a putative arterial progenitor expressed at the 10 ss within the lateral mesoderm
(Zhong et al., 2000), while flt4 is expressed in all angi-cell population. However, if this were the central role of
Vegf during this process, we would expect arterial oblasts beginning at this time and does not begin to
exhibit downregulation within the developing DA untilmarker gene expression at levels comparable to normal,
but with a reduced number of positive cells within the the 25 ss (Thompson et al., 1998). However, recent find-
ings suggest that the levels of grl may be an importantDA. This does not appear to be the case. We often
observe reduced expression of arterial markers through- determinant of its function (Thurston and Yancopoulos,
2001; Zhong et al., 2001). Thus, during intial exposureout the DA at lower doses of Vegf morpholino (A.M.V.
and N.D.L., unpublished data), suggesting that expres- to Vegf at the 10 ss, grl levels would be low within
arterial progenitor cells, allowing expression of flt4 insion level of these genes, rather than cell number, is
being affected. Thus, although we cannot dismiss other all angioblasts. As development proceeds, continuous
exposure to Vegf would induce the Notch signaling path-functions for Vegf at this time, we favor the possibility
that it is providing a signal for the induction of genes way, and the subsquent increase in the level of grl in
arterial progenitors would then lead to artery-specificthat play an important downstream role in arterial differ-
entiation. gene expression and the downregulation of flt4.
The general pattern of the vertebrate circulatory sys-Angioblasts within the zebrafish lateral mesoderm are
restricted to an arterial or venous lineage (Zhong et al., tem, as well as the basic signaling factors that regulate
its development, have been conserved throughout evo-2001) by the 7–12 ss, suggesting that the specification
of these cell fates occurs prior to this time. The compo- lution. It is now known that the early molecular dichot-
omy of arteries and veins is also conserved, as arteriesnents of the pathway we describe here (Figure 7) are
appropriately expressed to play a role at this stage. in a number of vertebrates can be discerned from veins
by virtue of specific molecular markers (Helbling et al.,vegf transcript is expressed within the somites in close
proximity to flk1-positive angioblasts that are migrating 2000; Lawson et al., 2001; Moyon et al., 2001; Wang
et al., 1998). Recent work has demonstrated arterial-to the midline at the 10 ss. In addition, shh is expressed
within the notochord at this stage (Odenthal et al., 1996). specific expression of notch1, notch3, and notch4 tran-
scripts in mouse embryos (Villa et al., 2001), consistentIt is unclear at this point whether Vegf is responsible for
the intial specification of arterial progenitors or their with our finding of DA-specific expression of notch5 in
zebrafish (Lawson et al., 2001), and suggests a similarsubsequent differentiation. It is possible that the specifi-
cation step occurs earlier, rendering lineage-restricted role for these factors in the development of the mouse
vasculature. Thus, it is likely that our present findingsarterial progenitors more sensitive to the apparent in-
ductive activity of Vegf. This may explain the differential will be relevant to the process of arterial-venous differ-
entiation during vascular development in other verte-effect of both Vegf and Notch activation on the arterial
identity of endothelial cells noted above; in both cases, brates as well as during neovascularization in adults. In
addition, our results further underscore the importancecells in the position of the DA, rather than the PCV,
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then transferred to agarose-coated or glass dishes in egg waterof establishing proper arterial and venous identity for
containing ethanol vehicle or 25 M cyclopamine. Typically, em-normal vascular development to occur in vertebrates
bryos were placed in cyclopamine at approximately 90% epibolyand demonstrate a complex genetic pathway that func-
and allowed to develop at 28.5C until 24 hpf. For heat shock experi-
tions to establish these differences before the onset of ments, embryos derived from a cross of TG(hsp70:gal4) and
circulation. TG(uas:notch1a-intra) adults were grown overnight at 24C. The
following morning, embryos (approximately the 16–18 ss) were
transferred into 50 ml Falcon tubes (Becton Dickinson, FranklinExperimental Procedures
Lakes, NJ) in 5 ml of egg water and placed in a 40C water bath for
20 min. Embryos were then rinsed out of the conical tubes into 10Fish Lines
cm plastic dishes (Becton Dickinson) and incubated at 28.5C forThe following mutant lines were used in this study: albb4, syut4
7–8 hr. Embryos were then dechorionated by pronase treatment(Schauerte et al., 1998), yot ty119 (Karlstrom et al., 1999), and mibta52b
(Westerfield, 1993) and fixed in 4% paraformaldehyde.(Jiang et al., 1996). Wild-type lines used were TL and EK. Fish han-
dling and breeding were performed according to standard proce-
dures (Westerfield, 1993). The TG(hsp70:gal4) (Lawson et al., 2001; Acknowledgments
Scheer et al., 2001) and TG(uas:notch1a-intra) (Scheer and Campos-
Ortega, 1999) fish lines have been described elsewhere. We would like to thank Elizabeth Laver and Steve Devoto for provid-
ing us with you-type mutant embryos and heterozygous carriers,
respectively, and Steve Ekker for the initial aliquot of Vegf morpho-Whole-Mount In Situ Hybridization and Sectioning
linos. We thank Beth Roman, Ramiah Subramanian, and Igor DawidWhole-mount in situ hybridization was performed as described else-
for helpful comments about the manuscript and Van Pham for excel-where (Hauptmann and Gerster, 1994) using the following probes:
lent technical assistance. B.M.W. is supported by NIH intramuralephrin-B2a (Lawson et al., 2001), flk1 (Thompson et al., 1998), flt4
grant ZO1 HD 01011, and N.D.L. is supported by a postdoctoral(Thompson et al., 1998), notch5 (Lawson et al., 2001), and vegf (see
associateship from the National Research Council.below). Where applicable, -galactosidase activity was detected
using X-Gal or Magenta-Gal (Biosynth) as chromogenic substrates.
For analysis of TG(hsp70:gal4);TG(uas:notch1a-intra) embryos, Received: December 7, 2001
notch5 and ephrin-B2a expression were scored, and embryos were Revised: April 3, 2002
separated prior to antibody staining. Subsequently, detection of
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